logo
Plus   Neg
Share
Email

Nordex Group Posts Wider Loss In H1, Sales Up 3.5%; Confirms Guidance

The Nordex Group (NRDXF.PK) said the business performed in line with the pattern anticipated by the Group in the first half of the year. After a weaker first half of 2019, the company expects a significant rise in activity levels with considerably higher sales in the second half of the year.

For the first-half, EBITDA was 17.1 million euros compared to 38.4 million euros, prior year, corresponding to an EBITDA margin of 1.7 percent compared to 4.0 percent. Consolidated net loss widened to a loss of 55.4 million euros from a loss of 40.3 million euros, last year.

First-half consolidated sales were 990.8 million euros compared to 957.1 million euros, previous year. Total output rose to 1.60 billion euros from 1.09 billion euros.

For 2019, the Nordex Group continues to expect consolidated sales of 3.2 billion euros to 3.5 billion euros, and an EBITDA margin of between 3.0 and 5.0 percent. The Group is now planning to invest around 160 million euros for 2019, primarily for additional rotor blade production capacity.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Pizza Hut's large Original Pan Pizza is now available at locations across the U.S. for $10.99. The fast food chain, a subsidiary of Yum! Brands Inc., said that fans can now get a large Original Pan Pizza with up to three of their favorite toppings, without needing to stretch their wallets. The Original Pan Pizza is a buttery golden-brown color. The U.S. Food and Drug Administration approved the first drug to treat adults and children aged 12 years and older with hypereosinophilic syndrome for six months or longer without another identifiable non-blood related cause of the disease. GlaxoSmithKline's Nucala (mepolizumab) is the first FDA-approved drug in nearly 14 years to treat this group of rare and debilitating blood diseases. Uber has won a legal battle to continue to operate in London, one of its largest markets. The ride-hailing company has been granted an 18-month license to operate in London after overturning the ban on an appeal for the second time. The Westminister Magistrates Court found Uber London Ltd. a "fit and proper" company to run the services in London.
RELATED NEWS
Follow RTT